Howard G. Welgus Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Howard G. Welgus is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 161,944 shares of ARQT, which is worth approximately $2.43 Million. The most recent transaction as insider was on Dec 02, 2024, when has been sold 10,000 shares (Common Stock) at a price of $12.51 per share, resulting in proceeds of $125,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K

15.63% 3M change

4.85% 12M change

Total Value Held $2.43 Million

Howard G. Welgus Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Open market or private sale	$125,100 $12.51 p/Share	10,000 Reduced 5.82%	161,944 Common Stock
Nov 01 2024	SELL Open market or private sale	$86,500 $8.65 p/Share	10,000 Reduced 5.5%	171,944 Common Stock
Oct 01 2024	SELL Open market or private sale	$92,600 $9.26 p/Share	10,000 Reduced 5.21%	181,944 Common Stock
Sep 03 2024	SELL Open market or private sale	$107,700 $10.77 p/Share	10,000 Reduced 4.95%	191,944 Common Stock
Aug 01 2024	SELL Open market or private sale	$98,699 $9.87 p/Share	10,000 Reduced 5.35%	176,953 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$11,111 $1.68 p/Share	6,614 Added 3.42%	186,953 Common Stock
Jul 01 2024	SELL Open market or private sale	$93,100 $9.31 p/Share	10,000 Reduced 5.25%	180,339 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$16,800 $1.68 p/Share	10,000 Added 4.99%	190,339 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	10,139 Added 5.32%	180,339 Common Stock
Jun 04 2024	SELL Open market or private sale	$80,100 $8.01 p/Share	10,000 Reduced 5.55%	170,200 Common Stock
Jun 04 2024	BUY Exercise of conversion of derivative security	$16,800 $1.68 p/Share	10,000 Added 5.26%	180,200 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	4,375 Added 2.51%	170,200 Common Stock
Apr 17 2023	SELL Open market or private sale	$118,745 $13.97 p/Share	8,500 Reduced 4.88%	165,825 Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	$14,280 $1.68 p/Share	8,500 Added 4.65%	174,325 Common Stock
Apr 06 2023	SELL Open market or private sale	$102,085 $12.01 p/Share	8,500 Reduced 4.88%	165,825 Common Stock
Apr 06 2023	BUY Exercise of conversion of derivative security	$14,280 $1.68 p/Share	8,500 Added 4.65%	174,325 Common Stock
Feb 15 2023	SELL Open market or private sale	$144,330 $16.98 p/Share	8,500 Reduced 4.88%	165,825 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$14,280 $1.68 p/Share	8,500 Added 4.65%	174,325 Common Stock
Jan 17 2023	SELL Open market or private sale	$116,620 $13.72 p/Share	8,500 Reduced 4.88%	165,825 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$14,280 $1.68 p/Share	8,500 Added 4.65%	174,325 Common Stock
Nov 15 2022	SELL Open market or private sale	$68,094 $20.01 p/Share	3,403 Reduced 2.01%	165,825 Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	$1,713 $1.68 p/Share	1,020 Added 0.6%	169,228 Common Stock
Oct 04 2022	SELL Open market or private sale	$121,740 $20.29 p/Share	6,000 Reduced 3.44%	168,208 Common Stock
Aug 15 2022	SELL Open market or private sale	$148,800 $24.8 p/Share	6,000 Reduced 3.33%	174,208 Common Stock
Jul 18 2022	SELL Open market or private sale	$146,400 $24.4 p/Share	6,000 Reduced 3.22%	180,208 Common Stock

HGW

Howard G. Welgus

Director

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account